From: Histone deacetylase (HDAC)-1, −2, −4 and −6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients’ survival
Clinicopathological variables
Overall survival
HR (95 % CI)
p-value
Histopathological stage (I + II / III + IV)
0.282 (0.143–0.556)
<0.0001
HDAC-6 expression (Low/ ≥ High)
0.716 (0.421–1.220)
0.2193